Tempus, a startup that battles cancer by utilizing technology, is now partnering with the University of Chicago. The goal of the partnership is to provide University of Chicago doctors with helpful data for treating breast cancer. The startup is redefining how genomic data is used in the medical field and developing a groundbreaking path for cancer treatment. Tempus is also Chicago based.
Ultimately, Tempus aims to collect data that will help doctors be able to better predict how patients will respond to treatments. To reach this goal, Tempus will collect data from over 1,000 patients. Furthering the research conducted on breast cancer is pivotal in making informed decisions about patient treatment and needs.
The technology that Tempus uses to conduct research with is so advanced that it actually produces real-time results. Machine learning and genomic sequencing allow doctors the ability to personalize treatments for every patient. Revolutionizing the way cancer treatment has been interpreted in the past, the research conducted at Tempus focuses on individual patient needs and learn more about Eric.
Groupon founder Eric Lefkofsky founded Tempus in 2015. Since its start, Tempus has also partnered with the University of Michigan, the Mayo Clinic, Lurie Comprehensive Cancer Center of Northwestern University, Rush University Medical Center, and Penn Medicine.
Lefkofsky, adjunct professor at the University of Chicago, is no stranger to the tech world. Lefkofsky is most well known for founding Groupon, but he also co-founded Uptake Technologies, Mediaocean, Echo Global Logistics, and Inner Workings.
In addition, he established the charitable organization Lefkofsky Family Foundation. Lefkofsky serves as Trustee of Lurie Children’s Hospital of Chicago and is on the Board of Trustees of Chicago’s Steppenwolf Theatre Company.
Perhaps one of the most important components of Lefkofskys work is his ability to deliver complex information to public in an accessible format. His blog shares stories related to work conducted at Tempus. The page includes stories about developing cures for cancer and the important role technology plays in this deeply challenging task. Through startups like Tempus, the contemporary world is coming closer to overcoming this challenge and tailoring cancer treatments to patients in a unique way never before seen and www.forbes.com/profile/eric-lefkofsky.